Adaptive Biotechnologies Corporation
25.55
+0.00% (최근 종가 25.55)
Company profile — from Yahoo Finance
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
Company information as provided by Yahoo Finance. Check the official filings before relying on it.
Market Cap
41억 달러
PER
-
Trailing 12 months
Forward P/E
-138.3배
Forward estimates
ROE
-38.8%
Return on equity
Dividend Yield
-
Beta
2.09
Volatility vs market
52주 범위에서 96% 지점입니다. 100%에 가까울수록 1년 최고가 부근입니다.
Source: Yahoo Finance
Average analyst price target
범위 $21.00 ~ $28.00 · 애널리스트 7명 · 종합의견 적극 매수 · 출처 Yahoo Finance
Analyst rating breakdown (2026-08-01)
월가는 이 종목을 뚜렷한 매수 우위로 보고 있습니다. (매수 12 · 관망 2 · 매도 0)
Revenue trend
3억 달러
2022–2025 회계연도 · 축 단위는 달러입니다.
Net income trend
-1억 달러
2022–2025 회계연도 · 축 단위는 달러입니다.
| Year | Revenue | Operating Income | Net Income | Operating Cash Flow | Net Margin |
|---|---|---|---|---|---|
| 2025 | 3억 달러 | -1억 달러 | -1억 달러 | -0억 달러 | -21.5% |
| 2024 | 2억 달러 | -2억 달러 | -2억 달러 | -1억 달러 | -89.1% |
| 2023 | 2억 달러 | -2억 달러 | -2억 달러 | -2억 달러 | -132.3% |
| 2022 | 2억 달러 | -2억 달러 | -2억 달러 | -2억 달러 | -108.0% |
회계연도 기준 실적입니다(달력 연도와 다를 수 있습니다). 출처: Yahoo Finance. 값이 없는 항목은 채우지 않고 "-"로 둡니다.
Prices, key stats, price targets, annual financials, filings and news above come straight from Yahoo Finance · Finnhub · SEC EDGAR, so they look the same for any US-listed ticker.
Support & resistance shows above whenever my TradingView indicator is sending alerts for the ticker. No alert is set up for this one yet, so there are no levels.
Option levels · MJM Score · REAL_BUY signals come through a Google Sheet and are still limited to the fixed watchlist. We leave them out rather than guess.
